William Weldon is Chairman and Chief Executive Officer of Johnson & Johnson and is the sixth Chairman in Johnson & Johnson's over one-hundred year history.
Weldon joined J&J as a sales representative for the McNeil Pharameutical division in 1971 and eventually became the head of J&J's Ethicon Endo-Surgery business in 1992. He became the head of J&J's pharmaceutical operations in 1998 and then became J&J's CEO in 2002. As CEO, Weldon engineered some of the largest acquisitions in J&J's history including the purchase of ALZA and Pfizer's consumer-health product line.
William Weldon received a BA in Biology from Quinnipiac University.
There is a lot of them. One of them is definitely the amount of money somebody has to pay for the product you want to deliver. So, I've had my knee replaced. The knee I have probably isn't a knee that we would sell in China or in some of those countries. We'd sell it to people that could afford ...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login